Public Profile

Crossject Société Anonyme

Crossject Société Anonyme, headquartered in France, is a pioneering company in the pharmaceutical industry, specialising in the development of innovative drug delivery systems. Founded in 2007, Crossject has made significant strides in creating its unique needle-free injection technology, which enhances patient comfort and compliance. The company focuses on several therapeutic areas, including pain management and emergency medicine, with its flagship product, Zeneo, designed to provide rapid and effective medication delivery. Crossject's commitment to innovation has positioned it as a leader in the market, with notable achievements in securing partnerships and advancing its product pipeline. With operations extending across Europe and beyond, Crossject continues to redefine the standards of drug administration, making healthcare more accessible and efficient.

DitchCarbon Score

How does Crossject Société Anonyme's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

21

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

4

Industry Benchmark

Crossject Société Anonyme's score of 21 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.

75%

Crossject Société Anonyme's reported carbon emissions

Crossject Société Anonyme, headquartered in France, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical and biotechnology sectors are increasingly focusing on sustainability and climate action. This includes setting science-based targets and committing to reducing their carbon footprints in line with global climate goals. However, without specific information from Crossject, it is unclear what initiatives or commitments they may have in place.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Crossject Société Anonyme's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Crossject Société Anonyme is headquartered in FR, which has a rank of very low, indicating very low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Crossject Société Anonyme is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Zogenix, Inc.

US
Chemicals nec
Updated 4 days ago

INJEX Pharma AG

DE
Other land transportation services
Updated 6 days ago

Eternity Healthcare, Inc.

HK
Health and social work services (85)
Updated 6 days ago

Antares Pharma, Inc.

US
Chemicals nec
Updated 6 days ago
DitchCarbon Score

Consort Medical plc

GB
Health and social work services (85)
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers